Literature DB >> 26346185

Impaired Glucose Tolerance in Healthy Men Treated with St. John's Wort.

Tore Bjerregaard Stage1, Per Damkier1,2, Mette Marie Hougaard Christensen1,2, Lene Buch-Krogh Nielsen3, Kurt Højlund4, Kim Brøsen1.   

Abstract

The purpose of this study was to examine whether the over-the-counter herbal medicinal plant St. John's wort affects glucose tolerance in healthy men. To do this, we included 10 healthy men who were examined by a 2-hr oral glucose tolerance test on three occasions: A: baseline; B: after 21 days of treatment with St. John's wort; and C: at least 6 weeks after the last capsule of St. John's wort was ingested. Plasma glucose, serum insulin and C-peptide levels were measured during an oral glucose tolerance test and used for estimation of area under the concentration-time curve (AUC) as well as indices of insulin sensitivity and insulin secretion. We found that treatment with St. John's wort increased total and incremental glucose AUC and 2-hr plasma glucose levels. Surprisingly, this effect was sustained and even further increased 6 weeks after the last capsule of St. John's wort was taken. No effect on indices of insulin sensitivity was seen, but indices of insulin secretion were reduced even after adjustment for insulin sensitivity. In conclusion, this study indicates that long-term treatment with St. John's wort may impair glucose tolerance by reducing insulin secretion in young, healthy men. The unregulated use of this over-the-counter drug might be a risk factor for impaired glucose tolerance and type 2 diabetes.
© 2015 Nordic Association for the Publication of BCPT (former Nordic Pharmacological Society).

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26346185     DOI: 10.1111/bcpt.12486

Source DB:  PubMed          Journal:  Basic Clin Pharmacol Toxicol        ISSN: 1742-7835            Impact factor:   4.080


  4 in total

1.  Expression dynamics of pregnane X receptor-controlled genes in 3D primary human hepatocyte spheroids.

Authors:  Tomas Smutny; Veronika Bernhauerova; Lucie Smutna; Jurjen Duintjer Tebbens; Petr Pavek
Journal:  Arch Toxicol       Date:  2021-10-23       Impact factor: 5.153

2.  PXR activation impairs hepatic glucose metabolism partly via inhibiting the HNF4α-GLUT2 pathway.

Authors:  Peihua Liu; Ling Jiang; Weimin Kong; Qiushi Xie; Ping Li; Xiaonan Liu; Jiayi Zhang; Ming Liu; Zhongjian Wang; Liang Zhu; Hanyu Yang; Ying Zhou; Jianjun Zou; Xiaodong Liu; Li Liu
Journal:  Acta Pharm Sin B       Date:  2021-10-16       Impact factor: 14.903

Review 3.  PXR and 4β-Hydroxycholesterol Axis and the Components of Metabolic Syndrome.

Authors:  Janne Hukkanen; Jukka Hakkola
Journal:  Cells       Date:  2020-11-09       Impact factor: 6.600

Review 4.  Protective Role of St. John's Wort and Its Components Hyperforin and Hypericin against Diabetes through Inhibition of Inflammatory Signaling: Evidence from In Vitro and In Vivo Studies.

Authors:  Michela Novelli; Pellegrino Masiello; Pascale Beffy; Marta Menegazzi
Journal:  Int J Mol Sci       Date:  2020-10-30       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.